Ignite Creation Date:
2024-05-06 @ 4:10 PM
Last Modification Date:
2024-10-26 @ 2:05 PM
Study NCT ID:
NCT04896541
Status:
COMPLETED
Last Update Posted:
2022-06-27
First Post:
2021-02-26
Brief Title:
Phase I Double-blind Placebo-controlled Study of AZD7442
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-14
Completion Date Type:
ACTUAL
First Submit Date:
2021-02-26
First Submit QC Date:
May 20 2021
Study First Post Date:
2021-05-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-24
Last Update Post Date:
2022-06-27
Last Update Post Date Type:
ACTUAL